RespireRx Pharmaceuticals Inc (RSPI): And: Attention Deficit Hyperactivity...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

RespireRx Pharmaceuticals Inc (RSPI)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	101
Boards Moderated	0
Alias Born	01/19/2024

Re: None

Wednesday, 05/01/2024 3:16:03 PM

Wednesday, May 01, 2024 3:16:03 PM

And:

Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Share & Trends Analysis, By Drug Type (Stimulants, Non-stimulants), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy), By Demographics, By Region and Forecast Period 2023 – 2030 (Updated Version Available)
Report ID - MRC_3748 | Pages - 209 | Category - Healthcare and Pharma

“Key Players: Adlon Therapeutics L.P., Amnel Pharmaceuticals LLC., Aytu Biopharma Inc., American Brivision (Holding) , Corporation, Cingulate Inc., Eli Lilly And Company, GSK plc, Johnson & Johnson Services Inc., Neos Therapeutics Inc., Novartis AG, Noven Pharmaceuticals Inc, Otsuka Pharmaceutical Co. Ltd, Purdue Pharma L.P., RespireRx Pharmaceuticals Inc., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Tris Pharma Inc.”

https://marketresearchcommunity.com/attention-deficit-hyperactivity-disorder-adhd-market/?trk=article-ssr-frontend-pulse_little-text-block

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM

More RSPI News

InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow